2LARTH(®), a micro-immunotherapy medicine, exerts anti-inflammatory effects in vitro and reduces TNF-α and IL-1β secretion

BACKGROUND: Tumor necrosis factor-α (TNF-α) and IL-1β are 2 pro-inflammatory cytokines known to be involved in rheumatic diseases. The therapeutic strategy used in micro-immunotherapy (MI) to reduce chronic inflammation and attenuate pain consists in mainly targeting these 2 cytokines. 2LARTH(®) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Floris, Ilaria, Appel, Kurt, Rose, Thorsten, Lejeune, Beatrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211308/
https://www.ncbi.nlm.nih.gov/pubmed/30464572
http://dx.doi.org/10.2147/JIR.S174326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211308/
https://www.ncbi.nlm.nih.gov/pubmed/30464572
http://dx.doi.org/10.2147/JIR.S174326

Ejemplares similares